PMV Pharmaceuticals, Inc. — Director's Dealing 2024

Jun 10, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2024-06-06

Reporting Person: Gallagher Carol Giltner (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-06	Stock Option (right to buy)	$1.65	A	67500	Acquired	2034-06-05	Common Stock (67500)	Direct
2024-06-07	Stock Option (right to buy)	$1.65	G	67500	Disposed	2034-06-05	Common Stock (67500)	Direct
2024-06-07	Stock Option (right to buy)	$1.65	G	67500	Acquired	2034-06-05	Common Stock (67500)	Indirect

Footnotes

F1: The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024.

F2: The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee.